A Chewing Study of Abuse-Deterrent Tablets Containing Polyethylene Oxide Using a Robotic Simulator

Abuse-deterrent formulations (ADFs) refer to formulation technologies aiming to deter the abuse of prescription drugs by making the dosage forms difficult to manipulate or extract the opioids. Assessments are required to evaluate the performance of the drugs through different routes including inject...

Full description

Saved in:
Bibliographic Details
Published inAAPS PharmSciTech Vol. 24; no. 8; p. 245
Main Authors Chen, Bangxiang, Zhang, Feng, Dhupia, Jaspreet, Morgenstern, Marco P., Costello, Mark, Boyce, Heather, Sun, Wei-Jhe, Raofi, Saeid, Tian, Li, Xu, Weiliang
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 29.11.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abuse-deterrent formulations (ADFs) refer to formulation technologies aiming to deter the abuse of prescription drugs by making the dosage forms difficult to manipulate or extract the opioids. Assessments are required to evaluate the performance of the drugs through different routes including injection, ingestion, and insufflation and also when the drugs are manipulated. Chewing is the easiest and most convenient way to manipulate the drugs and deserves investigation. Chewing is one of the most complex bioprocesses, where the ingested materials are subject to periodic tooth crushing, mixed through the tongue, and lubricated and softened by the saliva. Inter- and intra-subject variations in chewing patterns may result in different chewing performances. The purpose of this study is to use a chewing simulator to assess the deterrent properties of tablets made of polyethylene oxide (PEO). The simulator can mimic human molar grinding with variable chewing parameters including molar trajectory, chewing frequency, and saliva flow rate. To investigate the effects of these parameters, the sizes of the chewed tablet particles and the chewing force were measured to evaluate the chewing performance. Thirty-four out of forty tablets were broken into pieces. The results suggested that the simulator can chew the tablets into smaller particles and that the molar trajectory and saliva flow rate had significant effect on reducing the size of the particles by analysis of variance (ANOVA) while the effect of chewing frequency was not clear. Additionally, chewing force can work as an indicator of the chewing performance.
AbstractList Abuse-deterrent formulations (ADFs) refer to formulation technologies aiming to deter the abuse of prescription drugs by making the dosage forms difficult to manipulate or extract the opioids. Assessments are required to evaluate the performance of the drugs through different routes including injection, ingestion, and insufflation and also when the drugs are manipulated. Chewing is the easiest and most convenient way to manipulate the drugs and deserves investigation. Chewing is one of the most complex bioprocesses, where the ingested materials are subject to periodic tooth crushing, mixed through the tongue, and lubricated and softened by the saliva. Inter- and intra-subject variations in chewing patterns may result in different chewing performances. The purpose of this study is to use a chewing simulator to assess the deterrent properties of tablets made of polyethylene oxide (PEO). The simulator can mimic human molar grinding with variable chewing parameters including molar trajectory, chewing frequency, and saliva flow rate. To investigate the effects of these parameters, the sizes of the chewed tablet particles and the chewing force were measured to evaluate the chewing performance. Thirty-four out of forty tablets were broken into pieces. The results suggested that the simulator can chew the tablets into smaller particles and that the molar trajectory and saliva flow rate had significant effect on reducing the size of the particles by analysis of variance (ANOVA) while the effect of chewing frequency was not clear. Additionally, chewing force can work as an indicator of the chewing performance.
Abuse-deterrent formulations (ADFs) refer to formulation technologies aiming to deter the abuse of prescription drugs by making the dosage forms difficult to manipulate or extract the opioids. Assessments are required to evaluate the performance of the drugs through different routes including injection, ingestion, and insufflation and also when the drugs are manipulated. Chewing is the easiest and most convenient way to manipulate the drugs and deserves investigation. Chewing is one of the most complex bioprocesses, where the ingested materials are subject to periodic tooth crushing, mixed through the tongue, and lubricated and softened by the saliva. Inter- and intra-subject variations in chewing patterns may result in different chewing performances. The purpose of this study is to use a chewing simulator to assess the deterrent properties of tablets made of polyethylene oxide (PEO). The simulator can mimic human molar grinding with variable chewing parameters including molar trajectory, chewing frequency, and saliva flow rate. To investigate the effects of these parameters, the sizes of the chewed tablet particles and the chewing force were measured to evaluate the chewing performance. Thirty-four out of forty tablets were broken into pieces. The results suggested that the simulator can chew the tablets into smaller particles and that the molar trajectory and saliva flow rate had significant effect on reducing the size of the particles by analysis of variance (ANOVA) while the effect of chewing frequency was not clear. Additionally, chewing force can work as an indicator of the chewing performance.Abuse-deterrent formulations (ADFs) refer to formulation technologies aiming to deter the abuse of prescription drugs by making the dosage forms difficult to manipulate or extract the opioids. Assessments are required to evaluate the performance of the drugs through different routes including injection, ingestion, and insufflation and also when the drugs are manipulated. Chewing is the easiest and most convenient way to manipulate the drugs and deserves investigation. Chewing is one of the most complex bioprocesses, where the ingested materials are subject to periodic tooth crushing, mixed through the tongue, and lubricated and softened by the saliva. Inter- and intra-subject variations in chewing patterns may result in different chewing performances. The purpose of this study is to use a chewing simulator to assess the deterrent properties of tablets made of polyethylene oxide (PEO). The simulator can mimic human molar grinding with variable chewing parameters including molar trajectory, chewing frequency, and saliva flow rate. To investigate the effects of these parameters, the sizes of the chewed tablet particles and the chewing force were measured to evaluate the chewing performance. Thirty-four out of forty tablets were broken into pieces. The results suggested that the simulator can chew the tablets into smaller particles and that the molar trajectory and saliva flow rate had significant effect on reducing the size of the particles by analysis of variance (ANOVA) while the effect of chewing frequency was not clear. Additionally, chewing force can work as an indicator of the chewing performance.
ArticleNumber 245
Author Chen, Bangxiang
Dhupia, Jaspreet
Costello, Mark
Raofi, Saeid
Tian, Li
Boyce, Heather
Xu, Weiliang
Morgenstern, Marco P.
Zhang, Feng
Sun, Wei-Jhe
Author_xml – sequence: 1
  givenname: Bangxiang
  orcidid: 0000-0002-7508-8743
  surname: Chen
  fullname: Chen, Bangxiang
  email: bangxiang.chen@auckland.ac.nz
  organization: Department of Mechanical and Mechatronics Engineering, The University of Auckland
– sequence: 2
  givenname: Feng
  surname: Zhang
  fullname: Zhang, Feng
  organization: College of Pharmacy, The University of Texas at Austin
– sequence: 3
  givenname: Jaspreet
  surname: Dhupia
  fullname: Dhupia, Jaspreet
  organization: Department of Mechanical and Mechatronics Engineering, The University of Auckland
– sequence: 4
  givenname: Marco P.
  surname: Morgenstern
  fullname: Morgenstern, Marco P.
  organization: Food Materials & Structures, Plant & Food Research Ltd
– sequence: 5
  givenname: Mark
  surname: Costello
  fullname: Costello, Mark
  organization: College of Pharmacy, The University of Texas at Austin
– sequence: 6
  givenname: Heather
  surname: Boyce
  fullname: Boyce, Heather
  organization: Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration
– sequence: 7
  givenname: Wei-Jhe
  surname: Sun
  fullname: Sun, Wei-Jhe
  organization: Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration
– sequence: 8
  givenname: Saeid
  surname: Raofi
  fullname: Raofi, Saeid
  organization: Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration
– sequence: 9
  givenname: Li
  surname: Tian
  fullname: Tian, Li
  organization: Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration
– sequence: 10
  givenname: Weiliang
  surname: Xu
  fullname: Xu, Weiliang
  organization: Department of Mechanical and Mechatronics Engineering, The University of Auckland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38030835$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1LxDAURYMo6qh_wIVk6aaaj6ZNlsP4CYLi6Dqk7atGOokmKTr_3oyjIC5cPBJ457zFvRO06bwDhA4pOaGMyNNIGStVQRjPU5OqEBtolwpOCqU42_z130GTGF9IJqni22iHS8KJ5GIXNVM8e4Z3657wPI3dEvseT5sxQnEGCUIAl_CDaQZIEc-8S8a6FXvnhyWk5-UADvDth-0AP8bVwuB73_hkWzy3i3EwyYd9tNWbIcLB97uHHi_OH2ZXxc3t5fVselO0vKxTITn0Vdnxqs_TdYJJaEzFiFCMqF6yWklCStaIui-73jDR1IxQowQQxSvgfA8dr---Bv82Qkx6YWMLw2Ac-DFqJpWoKZWqyujRNzo2C-j0a7ALE5b6J5cMyDXQBh9jgF63NplkcwLB2EFTolcV6HUFOgervyrQK5X9UX-u_yvxtRQz7J4g6Bc_Bpfj-s_6BAojl58
CitedBy_id crossref_primary_10_1109_ACCESS_2025_3539623
Cites_doi 10.2165/11635860-000000000-00000
10.1208/s12249-019-1528-3
10.1016/j.jddst.2023.104450
10.1111/j.1365-2842.2011.02204.x
10.1080/096374800426948
10.1208/s12249-020-01646-8
10.1093/pm/pnw208
10.1016/j.jfoodeng.2007.02.008
10.1016/j.ijpharm.2022.122557
10.1111/joor.12149
10.1097/ALN.0000000000002031
10.1007/s12247-023-09731-8
10.1016/j.mechmachtheory.2008.06.003
10.1016/j.jbiomech.2010.03.002
10.1208/s12249-017-0947-2
10.1208/s12249-019-1452-6
10.1007/s40122-016-0062-1
10.1034/j.1601-0825.2002.02851.x
10.1111/pme.12834
10.1016/j.ijpharm.2016.12.015
10.1016/j.ijpharm.2022.122151
10.1016/j.ijpharm.2016.06.012
10.1016/j.ijpharm.2016.01.031
10.1016/j.chroma.2023.464186
10.36076/ppj/2017.7.E1003
10.1016/j.physbeh.2006.05.012
10.1016/j.ijpharm.2022.122486
10.1111/cts.13053
10.1177/0269216317717192
10.1080/03639045.2018.1504965
10.1016/j.ijpharm.2019.03.017
10.3390/pharmaceutics3010073
10.1007/s00221-001-0916-5
10.1016/j.xphs.2019.12.003
10.1115/1.4052379
10.1208/s12249-019-1565-y
10.1208/s12249-019-1594-6
10.1016/j.tifs.2013.10.005
10.1016/j.ifset.2020.102524
10.1016/j.ijpharm.2022.122430
10.1007/s00784-014-1266-6
10.1016/j.foodhyd.2007.11.013
10.1038/nmeth.2089
10.1016/j.ijpharm.2019.118602
10.1111/j.1365-2842.2010.02197.x
10.1016/j.cofs.2016.03.006
10.2319/061109-333.1
10.1016/j.ajodo.2009.07.025
10.1208/s12249-021-02169-6
10.1001/jamapsychiatry.2014.3043
10.1007/s10266-016-0292-z
ContentType Journal Article
Copyright The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2023. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.
Copyright_xml – notice: The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2023. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1208/s12249-023-02706-5
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1530-9932
ExternalDocumentID 38030835
10_1208_s12249_023_02706_5
Genre Journal Article
GroupedDBID ---
-56
-5G
-BR
-EM
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
203
23M
29~
2J2
2JN
2JY
2KG
2KM
2LR
2~H
30V
406
408
40D
40E
53G
5GY
5VS
67N
6J9
6NX
875
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AAKDD
AANZL
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABWNU
ABXPI
ACAOD
ACDTI
ACGFO
ACGFS
ACHSB
ACKNC
ACMDZ
ACMJI
ACMLO
ACOKC
ACOMO
ACPIV
ACREN
ACSNA
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADRFC
ADURQ
ADYFF
ADYOE
ADZKW
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFLOW
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGMZJ
AGQEE
AGQMX
AGRTI
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJRNO
AJZVZ
AKMHD
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
AXYYD
B-.
BA0
BAWUL
BGNMA
CS3
CSCUP
DDRTE
DIK
DNIVK
DPUIP
E3Z
EBLON
EBS
EIOEI
EMOBN
ESBYG
F5P
FERAY
FFXSO
FIGPU
FNLPD
FRRFC
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
HG6
HH5
HMJXF
HRMNR
IJ-
IKXTQ
IWAJR
IXC
IXD
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KOV
KPH
LGEZI
LLZTM
LOTEE
M4Y
MA-
NADUK
NPVJJ
NQJWS
NU0
NXXTH
O93
O9I
O9J
OK1
P2P
PF0
PT4
QOR
QOS
R89
R9I
ROL
RPM
RPX
RSV
S16
S27
S3A
S3B
SAP
SBL
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZN
T13
TR2
TSG
TSV
TUC
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK8
XSB
YLTOR
Z45
Z7U
Z7V
Z7W
Z7X
Z81
Z87
ZMTXR
ZOVNA
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c347t-83ef64d36fd36dd528eba62059209f827980042b57f4dfa25b7201a95e0936e33
IEDL.DBID U2A
ISSN 1530-9932
IngestDate Mon Jul 21 10:55:47 EDT 2025
Mon Jul 21 06:04:36 EDT 2025
Tue Jul 01 01:55:55 EDT 2025
Thu Apr 24 23:03:43 EDT 2025
Fri Feb 21 02:40:28 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords abuse-deterrent formulation
physical barrier
manipulation
simulated chewing
opioids
in vitro manipulation
Language English
License 2023. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c347t-83ef64d36fd36dd528eba62059209f827980042b57f4dfa25b7201a95e0936e33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-7508-8743
PMID 38030835
PQID 2895711896
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2895711896
pubmed_primary_38030835
crossref_citationtrail_10_1208_s12249_023_02706_5
crossref_primary_10_1208_s12249_023_02706_5
springer_journals_10_1208_s12249_023_02706_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-11-29
PublicationDateYYYYMMDD 2023-11-29
PublicationDate_xml – month: 11
  year: 2023
  text: 2023-11-29
  day: 29
PublicationDecade 2020
PublicationPlace Cham
PublicationPlace_xml – name: Cham
– name: United States
PublicationSubtitle An Official Journal of the American Association of Pharmaceutical Scientists
PublicationTitle AAPS PharmSciTech
PublicationTitleAbbrev AAPS PharmSciTech
PublicationTitleAlternate AAPS PharmSciTech
PublicationYear 2023
Publisher Springer International Publishing
Publisher_xml – name: Springer International Publishing
References Salem, Smith, Byrn (CR16) 2023; 84
Boyce, Dave, Scoggins, Gurvich, Smith, Byrn (CR49) 2020; 21
Chen (CR31) 2009; 23
Hoebler, Devaux, Karinthi, Belleville, Barry (CR40) 2000; 51
Litman, Pagán, Cicero (CR2) 2018; 128
Smith, Qu, Zheng, Baek, Gao, Buehler (CR18) 2023; 632
Harris, Cipriano, Colucci, Kapil, Geoffroy, Hopyan (CR28) 2017; 18
CR30
Woda, Mishellany-Dutour, Batier, François, Meunier, Reynaud (CR46) 2010; 43
Gudin (CR10) 2016; 5
Barakh Ali, Dharani, Afrooz, Mohamed, Cook, Khan (CR7) 2020; 21
Komagamine, Kanazawa, Minakuchi, Uchida, Sasaki (CR34) 2011; 38
Hemmingsen, Haahr, Gunnergaard, Cardot (CR6) 2011; 3
Komino, Shiga (CR35) 2017; 105
Externbrink, Sharan, Sun, Jiang, Keire, Xu (CR29) 2019; 561
Dharani, Barakh Ali, Afrooz, Mohamed, Cook, Khan (CR9) 2020; 109
Xu, Bronlund, Potgieter, Foster, Röhrle, Pullan (CR32) 2008; 43
Sohn, Choi (CR12) 2023
Hsu, Yang, Pavuluri, Abraham, Naraharisetti, Ashraf (CR26) 2019; 20
Bannwarth (CR1) 2012; 72
Lepley, Throckmorton, Parker, Buschang (CR42) 2010; 80
Chen, Dhupia, Morgenstern, Bronlund, Xu (CR47) 2022; 14
Feng, Wu, Balajee, Leissa, Ashraf, Xu (CR21) 2023; 631
van der Bilt (CR36) 2011; 38
Salles, Tarrega, Mielle, Maratray, Gorria, Liaboeuf (CR45) 2007; 82
Rezaei, Meruva, Donovan (CR4) 2021; 23
Xu, Gupta, Al-Ghabeish, Calderon, Khan (CR20) 2016; 500
Eberhard, Eberhard, Schneider, Schneider, Eiffler, Eiffler (CR41) 2015; 19
Vasiukhina, Gad, Wellington, Wilmes, Yeo, Solorio (CR13) 2022; 626
Panda, Chen, Benjamin (CR54) 2020; 66
Lepley, Throckmorton, Ceen, Buschang (CR39) 2011; 139
Meullenet, Gandhapuneni (CR44) 2006; 89
CR19
CR14
Qu, Smith, Feng, Wang, Pinto, Xu (CR17) 2023; 1705
Meruva, Donovan (CR48) 2019; 21
CR52
Tocce, Bishop, Balwinski, Watson, Lapham, Hewlett (CR51) 2019; 21
Peyron, Woda (CR55) 2016; 9
Maincent, Zhang (CR8) 2016; 510
Raofi, Kinjo, Sun, Li, Boyce, Natarajan (CR25) 2021; 14
Pedersen, Bardow, Jensen, Nauntofte (CR38) 2002; 8
Morell, Hernando, Fiszman (CR43) 2013; 35
Boyce, Smith, Byrn, Saluja, Qu, Gurvich (CR22) 2018; 19
Schneider, Rasband, Eliceiri (CR53) 2012; 9
Cicero, Ellis (CR3) 2015; 72
Rahman, Zidan, Korang-Yeboah, Yang, Siddiqui, Shakleya (CR5) 2017; 517
Peyron, Lassauzay, Woda (CR33) 2002; 142
Boyce, Ibrahim, Hoag (CR50) 2018; 44
Chen (CR23) 2017; 7
McCulloch, Sattar, Henderson, Lane, Bluebond-Langner (CR11) 2018; 32
Gudin, Levy-Cooperman, Kopecky, Fleming (CR24) 2015; 16
Kuninori, Tomonari, Uehara, Kitashima, Yagi, Miyawaki (CR37) 2014; 41
Ahmad, Omidian (CR27) 2019; 569
Kibria, Bandaranayake, Zheng, Lee, Cruz (CR15) 2023; 631
S Meruva (2706_CR48) 2019; 21
S Salem (2706_CR16) 2023; 84
HJ Boyce (2706_CR49) 2020; 21
J Gudin (2706_CR24) 2015; 16
SF Barakh Ali (2706_CR7) 2020; 21
WC Smith (2706_CR18) 2023; 632
C Lepley (2706_CR42) 2010; 80
X Xu (2706_CR20) 2016; 500
H Chen (2706_CR23) 2017; 7
L Rezaei (2706_CR4) 2021; 23
L Eberhard (2706_CR41) 2015; 19
HJ Boyce (2706_CR50) 2018; 44
2706_CR30
W Xu (2706_CR32) 2008; 43
G Kibria (2706_CR15) 2023; 631
T Kuninori (2706_CR37) 2014; 41
S Raofi (2706_CR25) 2021; 14
P Morell (2706_CR43) 2013; 35
MA Peyron (2706_CR33) 2002; 142
CR Lepley (2706_CR39) 2011; 139
A Vasiukhina (2706_CR13) 2022; 626
A Woda (2706_CR46) 2010; 43
A Pedersen (2706_CR38) 2002; 8
TJ Cicero (2706_CR3) 2015; 72
H Boyce (2706_CR22) 2018; 19
E Tocce (2706_CR51) 2019; 21
A Externbrink (2706_CR29) 2019; 561
R Litman (2706_CR2) 2018; 128
JS Sohn (2706_CR12) 2023
H Hsu (2706_CR26) 2019; 20
SC Harris (2706_CR28) 2017; 18
M Komino (2706_CR35) 2017; 105
J Chen (2706_CR31) 2009; 23
R McCulloch (2706_CR11) 2018; 32
B Chen (2706_CR47) 2022; 14
A van der Bilt (2706_CR36) 2011; 38
X Feng (2706_CR21) 2023; 631
B Bannwarth (2706_CR1) 2012; 72
2706_CR19
C Salles (2706_CR45) 2007; 82
2706_CR52
S Panda (2706_CR54) 2020; 66
J Maincent (2706_CR8) 2016; 510
2706_CR14
M Peyron (2706_CR55) 2016; 9
H Qu (2706_CR17) 2023; 1705
Y Komagamine (2706_CR34) 2011; 38
PH Hemmingsen (2706_CR6) 2011; 3
J Gudin (2706_CR10) 2016; 5
M-F Hoebler (2706_CR40) 2000; 51
CA Schneider (2706_CR53) 2012; 9
S Dharani (2706_CR9) 2020; 109
Z Rahman (2706_CR5) 2017; 517
R Ahmad (2706_CR27) 2019; 569
J Meullenet (2706_CR44) 2006; 89
References_xml – volume: 72
  start-page: 1713
  year: 2012
  end-page: 23
  ident: CR1
  article-title: Will abuse-deterrent formulations of opioid analgesics be successful in achieving their purpose?
  publication-title: Drugs.
  doi: 10.2165/11635860-000000000-00000
– volume: 21
  start-page: 2
  year: 2019
  ident: CR51
  article-title: Mechanical characterization of thermally annealed tablets containing polyethylene oxide for abuse deterrence
  publication-title: AAPS PharmSciTech.
  doi: 10.1208/s12249-019-1528-3
– volume: 84
  start-page: 104450
  year: 2023
  ident: CR16
  article-title: Degradation products of the abuse deterrent agent poly(ethylene) oxide under thermal manipulation conditions
  publication-title: J Drug Deliv Sci Technol.
  doi: 10.1016/j.jddst.2023.104450
– volume: 38
  start-page: 555
  year: 2011
  end-page: 63
  ident: CR34
  article-title: Association between masticatory performance using a colour-changeable chewing gum and jaw movement
  publication-title: J Oral Rehabil.
  doi: 10.1111/j.1365-2842.2011.02204.x
– volume: 51
  start-page: 353
  year: 2000
  end-page: 66
  ident: CR40
  article-title: Particle size of solid food after human mastication and in vitro simulation of oral breakdown
  publication-title: Int J Food Sci Nutr.
  doi: 10.1080/096374800426948
– volume: 21
  start-page: 99
  year: 2020
  ident: CR7
  article-title: Development of abuse-deterrent formulations using sucrose acetate isobutyrate
  publication-title: AAPS PharmSciTech.
  doi: 10.1208/s12249-020-01646-8
– volume: 18
  start-page: 1278
  year: 2017
  end-page: 91
  ident: CR28
  article-title: Oral abuse potential, pharmacokinetics, and safety of once-daily, single-entity, extended-release hydrocodone (HYD) in recreational opioid users
  publication-title: Pain Med.
  doi: 10.1093/pm/pnw208
– volume: 82
  start-page: 189
  year: 2007
  end-page: 98
  ident: CR45
  article-title: Development of a chewing simulator for food breakdown and the analysis of in vitro flavor compound release in a mouth environment
  publication-title: J Food Eng.
  doi: 10.1016/j.jfoodeng.2007.02.008
– volume: 632
  start-page: 122557
  year: 2023
  ident: CR18
  article-title: Determining critical overlap concentration of polyethylene oxide to support excipient safety assessment of opioid products
  publication-title: Int J Pharm.
  doi: 10.1016/j.ijpharm.2022.122557
– volume: 41
  start-page: 338
  year: 2014
  end-page: 45
  ident: CR37
  article-title: Influence of maximum bite force on jaw movement during gummy jelly mastication
  publication-title: J Oral Rehabil.
  doi: 10.1111/joor.12149
– volume: 128
  start-page: 1015
  year: 2018
  end-page: 26
  ident: CR2
  article-title: Abuse-deterrent opioid formulations
  publication-title: Anesthesiology.
  doi: 10.1097/ALN.0000000000002031
– year: 2023
  ident: CR12
  article-title: Design of abuse-deterrent formulations using various types of thermal deformed starch (TDS)
  publication-title: J Pharm Innov.
  doi: 10.1007/s12247-023-09731-8
– volume: 43
  start-page: 1353
  year: 2008
  end-page: 75
  ident: CR32
  article-title: Review of the human masticatory system and masticatory robotics
  publication-title: Mech Mach Theory.
  doi: 10.1016/j.mechmachtheory.2008.06.003
– volume: 43
  start-page: 1667
  year: 2010
  end-page: 73
  ident: CR46
  article-title: Development and validation of a mastication simulator
  publication-title: J Biomech.
  doi: 10.1016/j.jbiomech.2010.03.002
– volume: 19
  start-page: 1744
  year: 2018
  end-page: 57
  ident: CR22
  article-title: In vitro assessment of nasal insufflation of comminuted drug products designed as abuse deterrent using the vertical diffusion cell
  publication-title: AAPS PharmSciTech.
  doi: 10.1208/s12249-017-0947-2
– volume: 20
  start-page: 232
  year: 2019
  ident: CR26
  article-title: Effect of formulation variables on the nasal permeability and stability of naloxone intranasal formulations
  publication-title: AAPS PharmSciTech.
  doi: 10.1208/s12249-019-1452-6
– ident: CR19
– volume: 5
  start-page: 171
  year: 2016
  end-page: 86
  ident: CR10
  article-title: Oxycodone DETERx®: a novel abuse-deterrent, extended-release analgesic option for the treatment of patients with chronic pain
  publication-title: Pain Ther.
  doi: 10.1007/s40122-016-0062-1
– volume: 8
  start-page: 117
  year: 2002
  end-page: 29
  ident: CR38
  article-title: Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion
  publication-title: Oral Dis.
  doi: 10.1034/j.1601-0825.2002.02851.x
– volume: 16
  start-page: 2142
  year: 2015
  end-page: 51
  ident: CR24
  article-title: Comparing the effect of tampering on the oral pharmacokinetic profiles of two extended-release oxycodone formulations with abuse-deterrent properties
  publication-title: Pain Med.
  doi: 10.1111/pme.12834
– volume: 517
  start-page: 303
  year: 2017
  end-page: 11
  ident: CR5
  article-title: Effects of excipients and curing process on the abuse deterrent properties of directly compressed tablets
  publication-title: Int J Pharm.
  doi: 10.1016/j.ijpharm.2016.12.015
– volume: 626
  start-page: 122151
  year: 2022
  ident: CR13
  article-title: PLA-PCL microsphere formulation to deter abuse of prescription opioids by smoking
  publication-title: Int J Pharm.
  doi: 10.1016/j.ijpharm.2022.122151
– volume: 510
  start-page: 57
  year: 2016
  end-page: 72
  ident: CR8
  article-title: Recent advances in abuse-deterrent technologies for the delivery of opioids
  publication-title: Int J Pharm.
  doi: 10.1016/j.ijpharm.2016.06.012
– volume: 500
  start-page: 255
  year: 2016
  end-page: 67
  ident: CR20
  article-title: Risk based in vitro performance assessment of extended release abuse deterrent formulations
  publication-title: Int J Pharm.
  doi: 10.1016/j.ijpharm.2016.01.031
– volume: 1705
  start-page: 464186
  year: 2023
  ident: CR17
  article-title: Asymmetrical flow field flow fractionation for molar mass characterization of polyethylene oxide in abuse-deterrent formulations
  publication-title: J Chromatogr A.
  doi: 10.1016/j.chroma.2023.464186
– volume: 7
  start-page: 1003
  year: 2017
  end-page: 23
  ident: CR23
  article-title: Current impact and application of abuse-deterrent opioid formulations in clinical practice
  publication-title: Pain Physician.
  doi: 10.36076/ppj/2017.7.E1003
– volume: 89
  start-page: 39
  year: 2006
  end-page: 43
  ident: CR44
  article-title: Development of the BITE Master II and its application to the study of cheese hardness
  publication-title: Physiol Behav.
  doi: 10.1016/j.physbeh.2006.05.012
– volume: 631
  start-page: 122486
  year: 2023
  ident: CR21
  article-title: Understanding syringeability and injectability of high molecular weight PEO solution through time-dependent force-distance profiles
  publication-title: Int J Pharm.
  doi: 10.1016/j.ijpharm.2022.122486
– volume: 14
  start-page: 1977
  year: 2021
  end-page: 87
  ident: CR25
  article-title: Particle size affects pharmacokinetics of milled oxycodone hydrochloride tablet products following nasal insufflation in nondependent, recreational opioid users
  publication-title: Clin Transl Sci.
  doi: 10.1111/cts.13053
– volume: 32
  start-page: 554
  year: 2018
  end-page: 8
  ident: CR11
  article-title: Use of buccal morphine in the management of pain in children with life-limiting conditions: results of a laboratory study
  publication-title: Palliat Med.
  doi: 10.1177/0269216317717192
– volume: 44
  start-page: 1885
  year: 2018
  end-page: 94
  ident: CR50
  article-title: Physical barrier type abuse-deterrent formulations: monitoring sintering-induced microstructural changes in polyethylene oxide placebo tablets by near infrared spectroscopy (NIRS)
  publication-title: Drug Dev Ind Pharm.
  doi: 10.1080/03639045.2018.1504965
– volume: 561
  start-page: 305
  year: 2019
  end-page: 13
  ident: CR29
  article-title: An in vitro approach for evaluating the oral abuse deterrence of solid oral extended-release opioids with properties intended to deter abuse via chewing
  publication-title: Int J Pharm.
  doi: 10.1016/j.ijpharm.2019.03.017
– volume: 3
  start-page: 73
  year: 2011
  end-page: 87
  ident: CR6
  article-title: development of a new type of prolonged release hydrocodone formulation based on Egalet® ADPREM technology using in vivo–in vitro correlation
  publication-title: Pharmaceutics.
  doi: 10.3390/pharmaceutics3010073
– ident: CR14
– volume: 142
  start-page: 41
  year: 2002
  end-page: 51
  ident: CR33
  article-title: Effects of increased hardness on jaw movement and muscle activity during chewing of visco-elastic model foods
  publication-title: Exp Brain Res.
  doi: 10.1007/s00221-001-0916-5
– volume: 109
  start-page: 1338
  year: 2020
  end-page: 46
  ident: CR9
  article-title: Development of methamphetamine abuse–deterrent formulations using sucrose acetate isobutyrate
  publication-title: J Pharm Sci.
  doi: 10.1016/j.xphs.2019.12.003
– ident: CR30
– volume: 14
  start-page: 021012
  year: 2022
  ident: CR47
  article-title: Development of a biomimetic masticating robot for food texture analysis
  publication-title: J Mech Robot.
  doi: 10.1115/1.4052379
– volume: 21
  start-page: 28
  year: 2019
  ident: CR48
  article-title: Polyethylene oxide (PEO) molecular weight effects on abuse-deterrent properties of matrix tablets
  publication-title: AAPS PharmSciTech.
  doi: 10.1208/s12249-019-1565-y
– volume: 21
  start-page: 86
  year: 2020
  ident: CR49
  article-title: Physical barrier type abuse-deterrent formulations: mechanistic understanding of sintering-induced microstructural changes in polyethylene oxide placebo tablets
  publication-title: AAPS PharmSciTech.
  doi: 10.1208/s12249-019-1594-6
– volume: 35
  start-page: 18
  year: 2013
  ident: CR43
  article-title: Understanding the relevance of in-mouth food processing: a review of in vitro techniques
  publication-title: Trends Food Sci Technol.
  doi: 10.1016/j.tifs.2013.10.005
– volume: 66
  start-page: 102524
  year: 2020
  ident: CR54
  article-title: Development of model mouth for food oral processing studies: present challenges and scopes
  publication-title: Innov Food Sci Emerg Technol.
  doi: 10.1016/j.ifset.2020.102524
– volume: 631
  start-page: 122430
  year: 2023
  ident: CR15
  article-title: Stability of abuse-deterrent properties of PEO-based abuse-deterrent formulation
  publication-title: Int J Pharm.
  doi: 10.1016/j.ijpharm.2022.122430
– volume: 19
  start-page: 429
  year: 2015
  end-page: 36
  ident: CR41
  article-title: Particle size distributions determined by optical scanning and by sieving in the assessment of masticatory performance of complete denture wearers
  publication-title: Clin Oral Invest.
  doi: 10.1007/s00784-014-1266-6
– volume: 23
  start-page: 1
  year: 2009
  end-page: 25
  ident: CR31
  article-title: Food oral processing—a review
  publication-title: Food Hydrocoll.
  doi: 10.1016/j.foodhyd.2007.11.013
– volume: 9
  start-page: 671
  year: 2012
  end-page: 5
  ident: CR53
  article-title: NIH Image to ImageJ: 25 years of image analysis
  publication-title: Nat methods.
  doi: 10.1038/nmeth.2089
– volume: 569
  start-page: 118602
  year: 2019
  ident: CR27
  article-title: Development and in vitro evaluation of an abuse-deterrent formulation based on a crosslinked starch derivative
  publication-title: Int J Pharm.
  doi: 10.1016/j.ijpharm.2019.118602
– volume: 38
  start-page: 754
  year: 2011
  end-page: 80
  ident: CR36
  article-title: Assessment of mastication with implications for oral rehabilitation: a review
  publication-title: J Oral Rehabil.
  doi: 10.1111/j.1365-2842.2010.02197.x
– ident: CR52
– volume: 9
  start-page: 21
  year: 2016
  end-page: 8
  ident: CR55
  article-title: An update about artificial mastication
  publication-title: Curr Opin Food Sci.
  doi: 10.1016/j.cofs.2016.03.006
– volume: 80
  start-page: 295
  year: 2010
  end-page: 301
  ident: CR42
  article-title: Masticatory performance and chewing cycle kinematics—are they related?
  publication-title: Angle Orthod.
  doi: 10.2319/061109-333.1
– volume: 139
  start-page: 606
  year: 2011
  end-page: 13
  ident: CR39
  article-title: Relative contributions of occlusion, maximum bite force, and chewing cycle kinematics to masticatory performance
  publication-title: Am J Orthod Dentofacial Orthop.
  doi: 10.1016/j.ajodo.2009.07.025
– volume: 23
  start-page: 38
  year: 2021
  ident: CR4
  article-title: Effect of manufacturing process on the retention of abuse-deterrent properties of PEO-matrix tablets
  publication-title: AAPS PharmSciTech.
  doi: 10.1208/s12249-021-02169-6
– volume: 72
  start-page: 424
  year: 2015
  end-page: 30
  ident: CR3
  article-title: Abuse-deterrent formulations and the prescription opioid abuse epidemic in the United States: lessons learned from OxyContin
  publication-title: JAMA Psychiatry.
  doi: 10.1001/jamapsychiatry.2014.3043
– volume: 105
  start-page: 418
  year: 2017
  end-page: 25
  ident: CR35
  article-title: Changes in mandibular movement during chewing of different hardness foods
  publication-title: Odontology.
  doi: 10.1007/s10266-016-0292-z
– ident: 2706_CR30
– volume: 109
  start-page: 1338
  year: 2020
  ident: 2706_CR9
  publication-title: J Pharm Sci.
  doi: 10.1016/j.xphs.2019.12.003
– volume: 500
  start-page: 255
  year: 2016
  ident: 2706_CR20
  publication-title: Int J Pharm.
  doi: 10.1016/j.ijpharm.2016.01.031
– volume: 20
  start-page: 232
  year: 2019
  ident: 2706_CR26
  publication-title: AAPS PharmSciTech.
  doi: 10.1208/s12249-019-1452-6
– volume: 21
  start-page: 86
  year: 2020
  ident: 2706_CR49
  publication-title: AAPS PharmSciTech.
  doi: 10.1208/s12249-019-1594-6
– volume: 23
  start-page: 1
  year: 2009
  ident: 2706_CR31
  publication-title: Food Hydrocoll.
  doi: 10.1016/j.foodhyd.2007.11.013
– volume: 21
  start-page: 28
  year: 2019
  ident: 2706_CR48
  publication-title: AAPS PharmSciTech.
  doi: 10.1208/s12249-019-1565-y
– ident: 2706_CR19
– volume: 21
  start-page: 2
  year: 2019
  ident: 2706_CR51
  publication-title: AAPS PharmSciTech.
  doi: 10.1208/s12249-019-1528-3
– volume: 3
  start-page: 73
  year: 2011
  ident: 2706_CR6
  publication-title: Pharmaceutics.
  doi: 10.3390/pharmaceutics3010073
– volume: 8
  start-page: 117
  year: 2002
  ident: 2706_CR38
  publication-title: Oral Dis.
  doi: 10.1034/j.1601-0825.2002.02851.x
– volume: 35
  start-page: 18
  year: 2013
  ident: 2706_CR43
  publication-title: Trends Food Sci Technol.
  doi: 10.1016/j.tifs.2013.10.005
– volume: 16
  start-page: 2142
  year: 2015
  ident: 2706_CR24
  publication-title: Pain Med.
  doi: 10.1111/pme.12834
– volume: 84
  start-page: 104450
  year: 2023
  ident: 2706_CR16
  publication-title: J Drug Deliv Sci Technol.
  doi: 10.1016/j.jddst.2023.104450
– volume: 561
  start-page: 305
  year: 2019
  ident: 2706_CR29
  publication-title: Int J Pharm.
  doi: 10.1016/j.ijpharm.2019.03.017
– volume: 510
  start-page: 57
  year: 2016
  ident: 2706_CR8
  publication-title: Int J Pharm.
  doi: 10.1016/j.ijpharm.2016.06.012
– volume: 14
  start-page: 1977
  year: 2021
  ident: 2706_CR25
  publication-title: Clin Transl Sci.
  doi: 10.1111/cts.13053
– volume: 66
  start-page: 102524
  year: 2020
  ident: 2706_CR54
  publication-title: Innov Food Sci Emerg Technol.
  doi: 10.1016/j.ifset.2020.102524
– volume: 32
  start-page: 554
  year: 2018
  ident: 2706_CR11
  publication-title: Palliat Med.
  doi: 10.1177/0269216317717192
– volume: 128
  start-page: 1015
  year: 2018
  ident: 2706_CR2
  publication-title: Anesthesiology.
  doi: 10.1097/ALN.0000000000002031
– volume: 9
  start-page: 21
  year: 2016
  ident: 2706_CR55
  publication-title: Curr Opin Food Sci.
  doi: 10.1016/j.cofs.2016.03.006
– volume: 19
  start-page: 429
  year: 2015
  ident: 2706_CR41
  publication-title: Clin Oral Invest.
  doi: 10.1007/s00784-014-1266-6
– volume: 632
  start-page: 122557
  year: 2023
  ident: 2706_CR18
  publication-title: Int J Pharm.
  doi: 10.1016/j.ijpharm.2022.122557
– volume: 72
  start-page: 1713
  year: 2012
  ident: 2706_CR1
  publication-title: Drugs.
  doi: 10.2165/11635860-000000000-00000
– volume: 7
  start-page: 1003
  year: 2017
  ident: 2706_CR23
  publication-title: Pain Physician.
  doi: 10.36076/ppj/2017.7.E1003
– ident: 2706_CR14
– ident: 2706_CR52
– volume: 80
  start-page: 295
  year: 2010
  ident: 2706_CR42
  publication-title: Angle Orthod.
  doi: 10.2319/061109-333.1
– volume: 142
  start-page: 41
  year: 2002
  ident: 2706_CR33
  publication-title: Exp Brain Res.
  doi: 10.1007/s00221-001-0916-5
– volume: 44
  start-page: 1885
  year: 2018
  ident: 2706_CR50
  publication-title: Drug Dev Ind Pharm.
  doi: 10.1080/03639045.2018.1504965
– volume: 626
  start-page: 122151
  year: 2022
  ident: 2706_CR13
  publication-title: Int J Pharm.
  doi: 10.1016/j.ijpharm.2022.122151
– volume: 19
  start-page: 1744
  year: 2018
  ident: 2706_CR22
  publication-title: AAPS PharmSciTech.
  doi: 10.1208/s12249-017-0947-2
– volume: 9
  start-page: 671
  year: 2012
  ident: 2706_CR53
  publication-title: Nat methods.
  doi: 10.1038/nmeth.2089
– volume: 43
  start-page: 1667
  year: 2010
  ident: 2706_CR46
  publication-title: J Biomech.
  doi: 10.1016/j.jbiomech.2010.03.002
– volume: 72
  start-page: 424
  year: 2015
  ident: 2706_CR3
  publication-title: JAMA Psychiatry.
  doi: 10.1001/jamapsychiatry.2014.3043
– volume: 18
  start-page: 1278
  year: 2017
  ident: 2706_CR28
  publication-title: Pain Med.
  doi: 10.1093/pm/pnw208
– volume: 631
  start-page: 122486
  year: 2023
  ident: 2706_CR21
  publication-title: Int J Pharm.
  doi: 10.1016/j.ijpharm.2022.122486
– volume: 14
  start-page: 021012
  year: 2022
  ident: 2706_CR47
  publication-title: J Mech Robot.
  doi: 10.1115/1.4052379
– volume: 5
  start-page: 171
  year: 2016
  ident: 2706_CR10
  publication-title: Pain Ther.
  doi: 10.1007/s40122-016-0062-1
– volume: 38
  start-page: 555
  year: 2011
  ident: 2706_CR34
  publication-title: J Oral Rehabil.
  doi: 10.1111/j.1365-2842.2011.02204.x
– volume: 21
  start-page: 99
  year: 2020
  ident: 2706_CR7
  publication-title: AAPS PharmSciTech.
  doi: 10.1208/s12249-020-01646-8
– year: 2023
  ident: 2706_CR12
  publication-title: J Pharm Innov.
  doi: 10.1007/s12247-023-09731-8
– volume: 105
  start-page: 418
  year: 2017
  ident: 2706_CR35
  publication-title: Odontology.
  doi: 10.1007/s10266-016-0292-z
– volume: 41
  start-page: 338
  year: 2014
  ident: 2706_CR37
  publication-title: J Oral Rehabil.
  doi: 10.1111/joor.12149
– volume: 631
  start-page: 122430
  year: 2023
  ident: 2706_CR15
  publication-title: Int J Pharm.
  doi: 10.1016/j.ijpharm.2022.122430
– volume: 517
  start-page: 303
  year: 2017
  ident: 2706_CR5
  publication-title: Int J Pharm.
  doi: 10.1016/j.ijpharm.2016.12.015
– volume: 23
  start-page: 38
  year: 2021
  ident: 2706_CR4
  publication-title: AAPS PharmSciTech.
  doi: 10.1208/s12249-021-02169-6
– volume: 89
  start-page: 39
  year: 2006
  ident: 2706_CR44
  publication-title: Physiol Behav.
  doi: 10.1016/j.physbeh.2006.05.012
– volume: 51
  start-page: 353
  year: 2000
  ident: 2706_CR40
  publication-title: Int J Food Sci Nutr.
  doi: 10.1080/096374800426948
– volume: 82
  start-page: 189
  year: 2007
  ident: 2706_CR45
  publication-title: J Food Eng.
  doi: 10.1016/j.jfoodeng.2007.02.008
– volume: 38
  start-page: 754
  year: 2011
  ident: 2706_CR36
  publication-title: J Oral Rehabil.
  doi: 10.1111/j.1365-2842.2010.02197.x
– volume: 139
  start-page: 606
  year: 2011
  ident: 2706_CR39
  publication-title: Am J Orthod Dentofacial Orthop.
  doi: 10.1016/j.ajodo.2009.07.025
– volume: 43
  start-page: 1353
  year: 2008
  ident: 2706_CR32
  publication-title: Mech Mach Theory.
  doi: 10.1016/j.mechmachtheory.2008.06.003
– volume: 1705
  start-page: 464186
  year: 2023
  ident: 2706_CR17
  publication-title: J Chromatogr A.
  doi: 10.1016/j.chroma.2023.464186
– volume: 569
  start-page: 118602
  year: 2019
  ident: 2706_CR27
  publication-title: Int J Pharm.
  doi: 10.1016/j.ijpharm.2019.118602
SSID ssj0023193
Score 2.3672545
Snippet Abuse-deterrent formulations (ADFs) refer to formulation technologies aiming to deter the abuse of prescription drugs by making the dosage forms difficult to...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 245
SubjectTerms Advancements in Modified-release Oral Drug Delivery - Delivery throughout the Gastro-intestinal Tract
Biochemistry
Biomedical and Life Sciences
Biomedicine
Biotechnology
Delayed-Action Preparations
Humans
Mastication
Pharmacology/Toxicology
Pharmacy
Polyethylene Glycols
Research Article
Robotic Surgical Procedures
Tablets
Title A Chewing Study of Abuse-Deterrent Tablets Containing Polyethylene Oxide Using a Robotic Simulator
URI https://link.springer.com/article/10.1208/s12249-023-02706-5
https://www.ncbi.nlm.nih.gov/pubmed/38030835
https://www.proquest.com/docview/2895711896
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LbxMxELagvXBBvAmFapBQL8TCsdev46q0VCAggkQqJ2sd22qlkkXdRCX_nvE-UqGiShz25oe0n-2ZTzPzDSFvIquY9yxRI42iheGBGrtIVCHbCmihtW97HX7-ok7mxcdTedoXhTVDtvsQkmxf6lYBgZl3TY4BWYo2JscdkQfLu2RXZu6Op3jOyy3NwkMl-vKYf8_72wTd8CtvxERbU3P8gNzvfUQoO1Afkjtx-YgcTDuR6c0YZtc1U80YDmB6LT-9eUx8CYdn8QpXhpwkuIE6QenXTaTvc-pLVmOCWS6YWjWQtam6FhEwrS82EVFDKxTh6-_zEKFNJ4AKvtW-xr3g-_nP3OyrvnxC5sdHs8MT2ndSoAtR6BU1IiZVBKESfiFIbqKvFEfXijObDNfW5NvrpU5FSBWXXqNjUFkZmRUqCvGU7CzrZXxOQGlWFUmbCUusSMWkYiHyoHnSMWhvFyMyGX6uW_Qy47nbxYXLdAMBcR0gDgFxLSBOjsjb7ZxfncjGraNfD5g5vAs5wFEtY71uHJJHqZExWTUizzowt-sJk5V5BM4eD-i6_ro2t2z24v-G75F7uR99Llbk9iXZWV2u4yv0WlZ-n-yWH358OtpvD-sfCgPkiQ
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LbxMxELagHOBS8W54DhLqhVg49vp1jApVgLZEkEi9WevYFpVKtuomgvx7xvtIhYoqcdibx5b283hmNDPfEPI2spJ5zxI10ihaGB6osYtEFUZbAS209s2sw-MTNZkXn0_ladcUVvfV7n1KsnmpGwYEZt7XOQdkKdqYnHfEOFjeJnfQGTC5kGvOx9swCy-V6Npj_i33twm65ldey4k2pubwPtntfEQYt6A-ILfi8iHZn7Yk05shzK56puoh7MP0in5684j4MRz8iL9wZ8hFghuoEoz9uo70Qy59yWxMMMsNU6saMjdVOyICptX5JiJqaIUifP19FiI05QRQwrfKV3gWfD_7mYd9VZePyfzw4-xgQrtJCnQhCr2iRsSkiiBUwi8EyU30peLoWnFmk-Hamqy9XupUhFRy6TU6BqWVkVmhohBPyM6yWsY9AkqzskjajFhiRSpGJQuRB82TjkF7uxiQUf9z3aKjGc_TLs5dDjcQENcC4hAQ1wDi5IC828pctCQbN65-02PmUBdygqNcxmpdOwwepcaIyaoBedqCud1PmMzMI1B62KPrOnWtbzjs2f8tf03uTmbHR-7o08mX5-Renk2fGxe5fUF2Vpfr-BI9mJV_1VzYP8iR5eg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dSxwxEA-thdKXUu2H19aagvjSC-aSzdfjoT3UVj3aO_AtbC4JCror7h7t_fed7O6dFovQh31ZMgnsL7Mzw8z8BqGdQHPqHI1ECy1Jppkn2swikRBtebDQyjWzDk9O5eE0Oz4X5_e6-Jtq92VKsu1pSCxNRb1342PLhkD1XpXyQYaAvUk5SIiJxVP0DH7Hg3Svp2y4CrngDe9aZf4t97c5euBjPsiPNmZn9Aq97PxFPGwBXkdPQrGBdsct4fSijyd3_VNVH-_i8R0V9eI1ckO8fxF-wc44FQwucBnx0M2rQA5SGUxiZsKT1DxVVzjxVLXjIvC4vFoEQBAsUsBnvy99wE1pAc7xj9KVcBb-eXmdBn-Vt2_QdPR1sn9IuqkKZMYzVRPNQ5SZ5zLC471gOrhcMnCzGDVRM2V00mQnVMx8zJlwCpyE3IhADZeB87dorSiLsImwVDTPotIDGmkWs0FOfWBesaiCV87Memiw_Lh21lGOp8kXVzaFHgCIbQGxAIhtALGih76sZG5awo1HV39eYmZBL1KyIy9COa8sBJJCQfRkZA-9a8Fc7cd1YunhIN1foms71a0eOez9_y3fRs_HByP7_ej02wf0Io2pTz2MzHxEa_XtPGyBM1O7T819_QMY4uok
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Chewing+Study+of+Abuse-Deterrent+Tablets+Containing+Polyethylene+Oxide+Using+a+Robotic+Simulator&rft.jtitle=AAPS+PharmSciTech&rft.au=Chen%2C+Bangxiang&rft.au=Zhang%2C+Feng&rft.au=Dhupia%2C+Jaspreet&rft.au=Morgenstern%2C+Marco+P.&rft.date=2023-11-29&rft.issn=1530-9932&rft.eissn=1530-9932&rft.volume=24&rft.issue=8&rft_id=info:doi/10.1208%2Fs12249-023-02706-5&rft.externalDBID=n%2Fa&rft.externalDocID=10_1208_s12249_023_02706_5
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1530-9932&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1530-9932&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1530-9932&client=summon